Saturday, July 11, 2026

pharma · Sleep Deprivation

Shi Yang

Shi Yang is a pharma organization headquartered in CN. Primary therapeutic focus areas include Sleep Deprivation. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
3
Patents
0
Clinical program

Atorvastatin

Unknown · small molecule · Sleep Deprivation

Atorvastatin for Sleep Deprivation is a Unknown program (small_molecule) at Shi Yang with 1 ClinicalTrials.gov record(s).

← All Shi Yang projects Unknown small molecule active

Internal code S2015-091-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Shi Yang
Phase
Unknown
Modality
small_molecule
Indication
Sleep Deprivation
Status
active
Trials
1